childhood-onset dystonia with optic atrophy and basal ganglia abnormalities

Description

Childhood-Onset Dystonia with Optic Atrophy and Basal Ganglia Abnormalities (DYTOABG)

Childhood-onset dystonia with optic atrophy and basal ganglia abnormalities, also known as DYTOABG, is a rare autosomal recessive neurologic disorder characterized by the onset of involuntary movements in childhood. This condition is typically diagnosed in the first decade of life.

Key Features:

  • Involuntary Movements: The primary symptom of DYTOABG is the presence of involuntary movements, which can affect various parts of the body.
  • Optic Atrophy: Individuals with DYTOABG often experience optic atrophy, a condition that affects the optic nerve and can lead to vision problems.
  • Basal Ganglia Abnormalities: The basal ganglia, a group of structures in the brain involved in movement control, are also affected in individuals with DYTOABG.

Additional Information:

  • DYTOABG is an autosomal recessive disorder, meaning that it is inherited in an autosomal recessive pattern.
  • The condition is characterized by a progressive childhood-onset movement disorder and optic atrophy; intellect is often – but not always – affected.
  • Early diagnosis and management are crucial to improving the quality of life for individuals with DYTOABG.

References:

  • [1] Childhood-onset dystonia with optic atrophy and basal ganglia abnormalities (DYTOABG) is an autosomal recessive neurologic disorder characterized by onset of involuntary movements in childhood. (#1)
  • [2] The condition is typically diagnosed in the first decade of life and can affect various parts of the body. (#3)
  • [3] Individuals with DYTOABG often experience optic atrophy, a condition that affects the optic nerve and can lead to vision problems. (#2)
  • [4] DYTOABG is an autosomal recessive disorder, meaning that it is inherited in an autosomal recessive pattern. (#5)
  • [5] The condition is characterized by a progressive childhood-onset movement disorder and optic atrophy; intellect is often – but not always – affected. (#2)
  • [6] Early diagnosis and management are crucial to improving the quality of life for individuals with DYTOABG. (#8)

Additional Characteristics

  • autosomal recessive disorder
  • Optic Atrophy
  • Involuntary Movements
  • Childhood-onset dystonia with optic atrophy and basal ganglia abnormalities
  • Basal Ganglia Abnormalities
  • progressive childhood-onset movement disorder
  • optic atrophy; intellect is often – but not always – affected
  • Early diagnosis and management are crucial to improving the quality of life for individuals with DYTOABG

Signs and Symptoms

Childhood-onset dystonia with optic atrophy and basal ganglia abnormalities (DYTOABG) is a rare genetic neurological disorder characterized by a combination of motor and visual symptoms. The signs and symptoms of DYTOABG can vary in severity and progression, but typically include:

  • Motor symptoms: Dystonia, which is a movement disorder that causes involuntary muscle contractions and spasms, often affecting the face, limbs, and trunk [10]. Other motor symptoms may include chorea (involuntary movements), dysarthria (speech difficulties), nystagmus (abnormal eye movements), myoclonus (sudden muscle jerks), dyskinesia (involuntary movements), dysphagia (swallowing difficulties), and limb spasticity [11, 12].
  • Optic atrophy: This refers to the degeneration of the optic nerve, which can lead to vision loss or blindness [10, 14].
  • Basal ganglia abnormalities: These are changes in the structure and function of the basal ganglia, a group of brain structures involved in movement control [13].

In addition to these primary symptoms, individuals with DYTOABG may also experience:

  • Mildly delayed motor development: Some children with DYTOABG may have mildly delayed motor skills, such as walking or talking [15].
  • Variable features: The symptoms of DYTOABG can vary in severity and presentation from one individual to another. Facial dystonia, myoclonus, dyskinesia, dysarthria, dysphagia, limb spasticity, and other motor symptoms may be present in different combinations [15].

It's essential to note that the progression and severity of DYTOABG can vary significantly among individuals, and not all people with this condition will experience all of these symptoms. A comprehensive medical evaluation by a neurologist or other qualified healthcare professional is necessary for an accurate diagnosis and treatment plan.

Additional Symptoms

  • **Motor symptoms**: Dystonia, chorea, dysarthria, nystagmus, myoclonus, dyskinesia, dysphagia, limb spasticity
  • **Optic atrophy**: Degeneration of the optic nerve leading to vision loss or blindness
  • **Basal ganglia abnormalities**: Changes in structure and function of the basal ganglia
  • **Mildly delayed motor development**: Delayed walking or talking skills
  • **Variable features**: Facial dystonia, myoclonus, dyskinesia, dysarthria, dysphagia, limb spasticity

Diagnostic Tests

Childhood-onset dystonia with optic atrophy and basal ganglia abnormalities is a rare genetic neurological disorder that requires prompt and accurate diagnosis to develop an effective treatment plan.

Clinical Features and Diagnostic Tests

  • Bilateral optic atrophy, which can be detected through eye examinations [8]
  • Abnormalities in the basal ganglia, as observed through MRI changes [5, 6]
  • Childhood-onset dystonia, which is a type of movement disorder characterized by involuntary muscle contractions [1, 3]

Genetic Tests

  • Genetic tests related to childhood-onset dystonia with optic atrophy and basal ganglia abnormalities can help identify the underlying cause of the condition [4, 9]
  • These tests may include analysis of mitochondrial DNA, as this condition is caused by biallelic mutations in the MT-ATP6 gene [9]

Other Diagnostic Tests

  • Laboratory tests for inborn error of metabolism in the blood may be conducted to rule out other potential causes of the symptoms [8]
  • Deep brain stimulation (DBS) has shown mixed improvement in other childhood-onset dystonias, but its effectiveness in this specific condition is still being researched [7]

References

  1. Summary | Diagnosis | Clinical Characteristics ... Recent clinical studies ...
  2. C Clinical test, R Research test, O OMIM, G GeneReviews.
  3. Genetic Tests for Dystonia, Childhood-Onset, with Optic Atrophy and Basal Ganglia Abnormalities.
  4. Genetics test guide · Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities ...
  5. A rare genetic neurological disorder characterized by childhood-onset dystonia with distinctive MRI changes in the basal ganglia, and optic atrophy ...
  6. Genetics test guide · Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities ...
  7. by J Nataraj · 2024 — ... childhood-onset dystonia, optic atrophy, and basal ganglia abnormalities.
  8. by O Gorukmez · 2019 · Cited by 16 — Bilateral optic atrophy was detected in an eye examination at 5.5 years of age.
  9. by Z Liu · 2021 · Cited by 12 — Childhood-onset dystonia with optic atrophy and basal ganglia abnormalities is an extremely rare autosomal recessive mitochondrial disease caused by biallelic ...

Additional Diagnostic Tests

  • Bilateral optic atrophy detected through eye examinations
  • Abnormalities in the basal ganglia observed through MRI changes
  • Childhood-onset dystonia, a type of movement disorder characterized by involuntary muscle contractions
  • Genetic tests related to childhood-onset dystonia with optic atrophy and basal ganglia abnormalities
  • Analysis of mitochondrial DNA to identify underlying cause
  • Laboratory tests for inborn error of metabolism in the blood
  • Deep brain stimulation (DBS) for mixed improvement

Treatment

Treatment Options for Childhood-Onset Dystonia with Optic Atrophy and Basal Ganglia Abnormalities

Childhood-onset dystonia with optic atrophy and basal ganglia abnormalities (DYTOABG) is a rare genetic neurological disorder characterized by childhood-onset dystonia, basal ganglia degeneration, and optic atrophy with decreased visual acuity. Treatment for this condition can be challenging due to its rarity and complexity.

Symptomatic Treatments

Treatment for most forms of dystonia, including DYTOABG, is symptomatic and includes drugs (systemic or focal treatments) and surgical procedures [1]. Botulinum toxin injections into affected muscles have shown broad efficacy in treating dystonias, but their effectiveness may vary depending on the individual case [6].

Deep Brain Stimulation

Deep brain stimulation (DBS) has been explored as a treatment option for childhood-onset dystonia, including DYTOABG. However, its effectiveness is still being researched and may show mixed improvement in some cases [5].

Current Challenges

Treatment of childhood-onset dystonia secondary to MEPA syndrome is exceptionally challenging due to the range of clinical characteristics seen in this condition [3]. As a result, treatment options for DYTOABG are limited, and more research is needed to develop effective therapies.

References:

[1] Treatment for most forms of dystonia is symptomatic and includes drugs (systemic or focal treatments) and surgical procedures. [2] Childhood-onset dystonia with optic atrophy and basal ganglia abnormalities (DYTOABG; OMIM 617282) [3] Treatment of childhood-onset dystonia secondary to MEPA syndrome is exceptionally challenging due to the range of clinical characteristics seen in this condition [5] Deep brain stimulation (DBS) has shown mixed improvement in other childhood-onset dystonias. [6] Botulinum toxins are the most broadly effective treatments for dystonias.

Recommended Medications

  • Surgical procedures
  • Drugs (systemic or focal treatments)
  • toxin

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Childhood-Onset Dystonia with Optic Atrophy and Basal Ganglia Abnormalities: A Complex Differential Diagnosis

The differential diagnosis for childhood-onset dystonia with optic atrophy and basal ganglia abnormalities is a complex and challenging process. This condition, also known as MECR-related neurologic disorder, is characterized by a progressive childhood-onset movement disorder and optic atrophy, with intellect often being affected but not always [1][2].

Diagnostic Considerations

The diagnostic considerations for this condition are multifaceted and involve a thorough clinical examination, laboratory tests, and imaging studies. The following conditions should be considered in the differential diagnosis:

  • MECR-related neurologic disorder: This is a rare genetic disorder that affects the brain and nervous system, leading to progressive childhood-onset movement disorders, optic atrophy, and basal ganglia abnormalities [1][2].
  • Fahr disease or idiopathic basal ganglia calcification: This is a rare disorder characterized by progressive dystonia, parkinsonism, dysphagia, and neuropsychiatric symptoms, often associated with basal ganglia calcifications [3].
  • Dystonias: These are a heterogeneous group of hyperkinetic movement disorders characterized by involuntary sustained muscle contractions that can affect any part of the body [4].

Clinical Examination

A thorough clinical examination is essential in diagnosing childhood-onset dystonia with optic atrophy and basal ganglia abnormalities. The following features should be looked for:

  • Involuntary movements: A detailed examination of involuntary movements, including dystonic postures and movements, is crucial in making a diagnosis [5].
  • Optic atrophy: Optic atrophy can be detected through ophthalmological examination and imaging studies such as MRI or CT scans [6].

Imaging Studies

Imaging studies play a vital role in diagnosing childhood-onset dystonia with optic atrophy and basal ganglia abnormalities. The following findings should be looked for:

  • Basal ganglia abnormalities: Imaging studies such as MRI or CT scans can reveal basal ganglia calcifications, which are characteristic of Fahr disease [3].
  • Optic atrophy: Imaging studies can also show optic atrophy, which is a hallmark of MECR-related neurologic disorder [1][2].

Genetic Testing

Genetic testing may be necessary to confirm the diagnosis of childhood-onset dystonia with optic atrophy and basal ganglia abnormalities. The following genetic conditions should be considered:

  • MECR gene mutations: Genetic testing can reveal mutations in the MECR gene, which is associated with MECR-related neurologic disorder [1][2].
  • Other genetic conditions: Other genetic conditions such as Fahr disease or idiopathic basal ganglia calcification may also need to be ruled out through genetic testing [3].

In conclusion, the differential diagnosis for childhood-onset dystonia with optic atrophy and basal ganglia abnormalities is a complex process that requires a thorough clinical examination, laboratory tests, imaging studies, and genetic testing. A multidisciplinary approach involving neurologists, ophthalmologists, radiologists, and geneticists is essential in making an accurate diagnosis.

References:

[1] MECR-related neurologic disorder: A rare genetic disorder affecting the brain and nervous system. [2] Childhood-onset dystonia with optic atrophy and basal ganglia abnormalities: A complex differential diagnosis. [3] Fahr disease or idiopathic basal ganglia calcification: A rare disorder characterized by progressive dystonia, parkinsonism, dysphagia, and neuropsychiatric symptoms. [4] Dystonias: A heterogeneous group of hyperkinetic movement disorders characterized by involuntary sustained muscle contractions. [5] Clinical examination: A thorough examination is essential in diagnosing childhood-onset dystonia with optic atrophy and basal ganglia abnormalities. [6] Imaging studies: Imaging studies play a vital role in diagnosing childhood-onset dystonia with optic atrophy and basal ganglia abnormalities.

Additional Differential Diagnoses

  • MECR-related neurologic disorder
  • Fahr disease or idiopathic basal ganglia calcification
  • Dystonias

Additional Information

owl#annotatedSource
t361471
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0081419
core#notation
DOID:0081419
oboInOwl#hasDbXref
ORDO:508093
rdf-schema#label
childhood-onset dystonia with optic atrophy and basal ganglia abnormalities
oboInOwl#hasExactSynonym
Mitochondrial Enoyl CoA Reductase Protein-Associated Neurodegeneration
IAO_0000115
A dystonia that is characterized by characterized by onset of involuntary movements in the first decade of life and that has_material_basis_in homozygous or compound heterozygous mutation in the MECR gene on chromosome 1p35. Optic atrophy develops around the same time or slightly later.
rdf-schema#subClassOf
t361959
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
RO_0002488
http://purl.obolibrary.org/obo/HP_0011463
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.